Exabis Library
Welcome to the e-CCO Library!
P707: Microbial signature of the colon is not associated with response to vedolizumab in Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P707: Paediatric IBD patients do not meet the daily recommendations of vitamin D and calcium intake: survey based analysis in a tertiary centre
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P707: Using urgent small bowel ultrasound (SBUS) as a tool for decision-making in patients with inflammatory bowel disease (IBD): retrospective analysis of United Kingdom (UK) patients' outcome.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P708 The effect of psychotherapy on quality of life in inflammatory bowel disease patients: A systematic literature review
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P708: Helicobacter pylori and IBD are inversely related, suggesting that individuals infected with the bacteria are less susceptible to the disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P708: Home-based infusion therapy for biologic agent administration as a therapeutic option for patients with inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P708: Ileal involvement defined by Montreal classification in Crohn’s disease is associated with a distinct microbial composition in ileal and colonic mucosa
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P708: Post-COVID-19 and Quality of Life in Patients with Immune Mediated Inflammatory Diseases
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P708: Prospective study to predict psychological morbidity in young people with inflammatory bowel disease using novel risk assessment tool
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P709 Is azathioprine safe as long-term treatment in paediatric patients with inflammatory bowel disease?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P709: Distinct Pattern of Gut Microbial Dysbiosis in Crohn's Disease and Intestinal Tuberculosis - A Machine Learning-based classification model
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P709: Early measurement of serum cytokines as predictor of clinical and endoscopic outcome to vedolizumab in patients with ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P709: Endoscopic healing and clinical remission after administration of adalimumab to patients with Crohn's disease of the small intestine
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P709: inflammatory bowel disease and colorectal cancer: analysis of a single center retrospective chart review
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P709: Is there a difference in adalimumab drug levels according to pen vs. syringe use: An international, multi-centre retrospective analysis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P710 The influence of probiotics to the efficacy of 5-ASA for the patients of ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P710: Changes of gut microbiome after anti-TNF-α therapy and the prediction of clinical remission in patients with active ulcerative colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P710: Efficacy of therapeutic intervention for ulcerative colitis patients with the Mayo Endoscopic Score of 1
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P710: Evaluation of helminth extracellular vesicles as a novel therapeutic for inflammatory bowel disease in murine models of colitis
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P710: The use of first-line biologics in patients with Crohn’s disease in Norway from 2011 to 2016
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM